This document is a USPTO patent application (US20260083853A1) for "CD70 antibody drug conjugates and methods of using the same" for the treatment of cancer and autoimmune diseases. The application was filed on October 25, 2023, by inventors Xiao Shang, Haidong Liu, Julia Gavrilyuk, Baiteng Zhao, Tae Han, and Zhu Chen.

As this is a patent application, it does not impose direct compliance obligations on regulated entities. However, it signifies potential future developments in therapeutic agents and may be of interest to pharmaceutical and biotechnology companies for competitive intelligence and R&D strategy. No compliance actions or deadlines are associated with this filing.